MoVIHvax

Spain
|
2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox
  • Blood sample

Mpox paediatric registry

Spain Mexico United States of America Congo (Democratic Republic of the)
|
2023
  • General population
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

Norz

Germany
|
2022-2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

Nozza

Italy
|
2022-2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox

Ortiz

Spain
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox

LongCoCid

Germany
|
2022
  • General population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

Long-Neuro-COVID-19

Germany
|
2020-2024
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

LoTECA

Norway
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Adolescents (12-17 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

LUNGTERMcov

Switzerland
|
2021-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • Intensive care unit
  • SARS-CoV-2
  • Post COVID-19 condition

Mailhe

France
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

MASH-1

United Kingdom France Spain Poland
|
2024-2024
  • Adults (18-64 years)
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • PrEP users
  • People living with HIV
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox

Mazzitelli

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir